Gilead Sciences, Inc. focuses on developing therapies for serious diseases, with a primary emphasis on virology, oncology, and inflammation. In virology, the company works on treatments for HIV and viral hepatitis. In oncology, Gilead develops next-generation cancer therapies and seeks to expand access to care. In the area of inflammation, the company aims to provide therapies for inflammatory and fibrotic diseases.
| GILD | GILD | Shares | USD | XNGS |
| GILD | GILD | Shares | USD | XNGS |
No recent RNS announcements for 1GILD across 1GILD, 2GILD, 4GILD, GILD.
No recent RNS announcements for 1GILD across 1GILD, 2GILD, 4GILD, GILD.